HomeNewsBusinessMarkets10 years' data suggest bulls & bears lock horns in March. Will bears take control in 2021?

10 years' data suggest bulls & bears lock horns in March. Will bears take control in 2021?

The silver lining is that the markets are in an uptrend. As long as India Inc continues to deliver, and micro and macro data remain strong, most dips will be bought into, say analysts.

March 05, 2021 / 13:35 IST
Story continues below Advertisement
AI Champdany Industries | Due to acute shortage of raw jute and low productivity, the company is compelled to declare temporary suspension of work at its Wellington Jute Mill-Rishra with effect from February 27 till further notice.
AI Champdany Industries | Due to acute shortage of raw jute and low productivity, the company is compelled to declare temporary suspension of work at its Wellington Jute Mill-Rishra with effect from February 27 till further notice.

After closing February with gains of more than 6 percent, which way will Indian markets head in March? Experts say that stocks are likely to maintain the uptrend in the current month too, although volatility is likely to increase, and rising US bond yields and crude oil prices play spoilsport.

Story continues below Advertisement

Historically, bulls and bears have remained in equal control of D-Street in the last 10 years, data from AceEquity showed.

In five instances, the Nifty jumped over 10 percent in March 2016, followed by 9 percent in March 2011, and over 7 percent in March 2019 - three of the biggest gains in the month.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show

Experts are of the view that there could be some pressure on the debt market, if US Treasury Bond Yields continue to rise.

“FII flows will see a fall in the bond market as yields will rise. The increasing inflation numbers and probability of a hike in interest rate will increase,” Vishal Wagh, Research Head, Bonanza Portfolio Ltd, told Moneycontrol.

The US yields rose quite substantially last month, with the benchmark 10-Year Yield surging to around 1.6 percent, a level that was last seen a year ago. That said, yields have cooled off a bit since Friday, with the 10-Year yield softening over 15 basis points, having moved above the lows of 2012 and 2016.

“For now, one needs to focus on how the US yields move from here. If Friday’s reversal causes US yields to soften a bit over the next few days, risk aversion is likely to recede across the board,” says Chinchalkar of FYERS.

“That said, if nominal US yields continue to rise and real US yields inch closer towards becoming positive, we could see the second wave of selling in the global bond and equity markets,” he said.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking investment decisions.